文献速递冠心病

年龄对稳定胸痛患者CT与有创冠脉造影结局的影响:DISCHARGE随机临床试验预设二次分析

Age and Computed Tomography and Invasive Coronary Angiography in Stable Chest Pain: A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

该预设二次分析基于DISCHARGE随机临床试验,纳入3561例稳定胸痛且阻塞性冠心病中间概率患者,随机接受CT优先或有创冠脉造影策略。中位随访3.5年时,年龄与随机分组对主要不良心血管事件(MACE)无交互作用,但对主要操作相关并发症存在交互作用,年轻患者中CT与较低并发症风险相关。

要点

  • 年龄不影响CT与有创冠脉造影策略对MACE的比较效果。
  • 年龄与随机分组对主要操作相关并发症存在交互作用。
  • 年轻患者中CT策略与较低的主要操作相关并发症风险相关。

核心结论

  • 年龄未改变随机分组对主要结局MACE的影响,但改变了其对主要操作相关并发症的影响。
  • 结果提示年轻患者中CT与较低的主要操作相关并发症风险相关。

研究设计与样本

  • DISCHARGE试验为评估者盲法随机临床试验,2015年10月至2019年4月在26个欧洲中心开展。
  • 纳入因稳定胸痛转诊有创冠脉造影且阻塞性冠心病中间概率的患者,按意向性治疗分析。
  • 共3561例患者,平均(SD)年龄60.1(10.1)岁,女性2002例(56.2%)。
  • 患者随机分配至CT优先策略或直接有创冠脉造影策略。
  • 本分析为预设的年龄二次分析,主要结局为中位随访3.5年时的MACE。

主要发现

  • 2360例(66.3%)年龄小于65岁,982例(27.6%)为65至75岁,219例(6.1%)大于75岁。
  • 3523例(99%)患者在中位(IQR)随访3.5(2.9-4.2)年时获得主要结局MACE数据。

临床怎么用

  • 对稳定胸痛且阻塞性冠心病中间概率的患者,年龄不应作为选择CT优先或有创冠脉造影策略以影响MACE的依据。
  • 在年轻患者中,选择CT优先策略可能降低主要操作相关并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The effectiveness and safety of computed tomography (CT) and invasive coronary angiography (ICA) in different age groups is unknown. OBJECTIVE: To determine the association of age with outcomes of CT and ICA in patients with stable chest pain. DESIGN, SETTING, AND PARTICIPANTS: The assessor-blinded Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial was conducted between October 2015 and April 2019 in 26 European centers. Patients referred for ICA with stable chest pain and an intermediate probability of obstructive coronary artery disease were analyzed in an intention-to-treat analysis. Data were analyzed from July 2022 to January 2023. INTERVENTIONS: Patients were randomly assigned to a CT-first strategy or a direct-to-ICA strategy. MAIN OUTCOMES AND MEASURES: MACE (ie, cardiovascular death, nonfatal myocardial infarction, or stroke) and major procedure-related complications. The primary prespecified outcome of this secondary analysis of age was major adverse cardiovascular events (MACE) at a median follow-up of 3.5 years. RESULTS: Among 3561 patients (mean [SD] age, 60.1 [10.1] years; 2002 female [56.2%]), 2360 (66.3%) were younger than 65 years, 982 (27.6%) were between ages 65 to 75 years, and 219 (6.1%) were older than 75 years. The primary outcome was MACE at a median (IQR) follow-up of 3.5 (2.9-4.2) years for 3523 patients (99%). Modeling age as a continuous variable, age, and randomization group were not associated with MACE (hazard ratio, 1.02; 95% CI, 0.98-1.07; P for interaction = .31). Age and randomization group were associated with major procedure-related complications (odds ratio, 1.15; 95% CI, 1.05-1.27; P for interaction = .005), which were lower in younger patients. CONCLUSIONS AND RELEVANCE: Age did not modify the effect of randomization group on the primary outcome of MACE but did modify the effect on major procedure-related complications. Results suggest that CT was associated with a lower risk of major procedure-related complications in younger patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02400229.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Bosserdt, Serna-Higuita, Feuchtner, et al. Age and Computed Tomography and Invasive Coronary Angiography in Stable Chest Pain: A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 38416472. doi:10.1001/jamacardio.2024.0001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。